Back to Search
Start Over
[Orphan diseases: evaluations of new treatments].
- Source :
-
La Revue de medecine interne [Rev Med Interne] 2007 Oct; Vol. 28 Suppl 2, pp. S202-5. - Publication Year :
- 2007
-
Abstract
- The new treatments of orphan diseases must be assessed according to the methodologic rules of therapeutic trials, in order to ensure clinically and statistically significant evaluations: randomized controled trials, single primary end-point, statistically significant and clinically relevant efficience. Although these rules may be relaxed in orphan diseases, they have to maintain the standard of therapeutic efficiency.
Details
- Language :
- French
- ISSN :
- 0248-8663
- Volume :
- 28 Suppl 2
- Database :
- MEDLINE
- Journal :
- La Revue de medecine interne
- Publication Type :
- Academic Journal
- Accession number :
- 18228689
- Full Text :
- https://doi.org/10.1016/s0248-8663(07)78883-5